A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.
Researchers at the Institute of Bioengineering and Nanotechnology (IBN), Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS) have successfully developed a miniaturized device that can be used to detect the highly pathogenic avian flu (H5N1) virus.
As the cold and flu season approaches the BMA is calling on adults and children to follow basic hygiene rules to prevent the spread of infections.
The influenza A virus does not lie dormant during summer but migrates globally and mixes with other viral strains before returning to the Northern Hemisphere as a genetically different virus, according to biologists who say the finding settles a key debate on what the virus does during the summer off season when it is not infecting people.
The U.S. Food and Drug Administration approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.
Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, announced data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary adjuvant achieved a high immune response at the lowest dose of H5N1 antigen reported to date.
The southern Chinese city of Guangzhou will cull another 10,000 domestic fowls, following the outbreak of the deadly H5N1-type bird flu among ducks, local officials said today.
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) announced that its researchers have discovered a monoclonal antibody that is active against H5N1 avian influenza. The studies will be presented at the 5th International Bird Flu Summit scheduled for September 27 and 28 in Las Vegas, Nevada.
Recent findings from study of incentives, decision-making, and influenza epidemics may offer guidance on public health policy. A team of three researchers at the University of California in Los Angeles, two of them physicists, have found that while family-based vaccination incentives fail to prevent severe epidemics.
HHS Secretary Mike Leavitt today announced that the Department is making available another $75 million to states, territories and four metropolitan areas to help strengthen their capacity to respond to a pandemic influenza outbreak.